Syros Pharmaceuticals Inc
LSE:0LC7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Syros Pharmaceuticals Inc
LSE:0LC7
|
US |
|
Imugene Ltd
ASX:IMU
|
AU |
|
F
|
Florida Canyon Gold Inc
XTSX:FCGV
|
CA |
|
B
|
Better Plant Sciences Inc
F:YG3A
|
CA |
|
REA Group Ltd
ASX:REA
|
AU |
|
P
|
Petroleo Brasileiro SA Petrobras
XBER:PJX
|
BR |
|
F
|
Flutter Entertainment PLC
ISEQ:FLTR
|
IE |
|
Paccar Inc
NASDAQ:PCAR
|
US |
|
U
|
UPM-Kymmene Oyj
XBER:RPL
|
FI |
|
Fresenius SE & Co KGaA
MIL:FRE
|
DE |
|
J
|
Just Eat Takeaway.com NV
SWB:T5W
|
NL |
|
IST:ENERY.E
|
TR | |
|
GlobalData PLC
F:YK6
|
UK |
|
A
|
Aleafia Health Inc
OTC:ALEAF
|
CA |
Shareholder Yield
Current shareholder yield for 
0LC7 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0LC7 Price
Syros Pharmaceuticals Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -75% |
| Market Capitalization | 5.4k USD |
| Shares Outstanding | 26 830 000 |
| Percentage of Shares Shorted |
N/A
|
